News & Views
Qlucore targets academic and commercial biotech, life science markets
Jan 21 2013
Qlucore, a leader in the development of bioinformatics software, has announced an agency agreement with Novo Newton Scientific Ltd, covering Qlucore's Omics Explorer software in Ireland, Spain, Italy and South Africa. The company, which started from a collaborative research project at Lund University, Sweden, has also signed a distribution agreement in Japan, and raised investment finance for expansion into the US market.
Omics Explorer software enables researchers to study their own data and to look for patterns and structures; it is built on the premise that visualization is one of the key drivers for effective analysis of complex data. It is used in 19 countries by large pharmaceutical and biotech companies and renowned academic institutions.
Carl-Johan Ivarsson, President, Qlucore said: "We are delighted that Novo Newton Scientific Ltd will be distributing our software into these territories. This will increase our market presence. We have been very impressed with the firm's professionalism and we are looking forward to working with the team."
Tom Nugent , Chief Financial Officer , Novo Newton Scientific Ltd commented. "We are excited to collaborate with Qlucore and to be promoting Qlucore Omics Explorer. Qlucore is well respected in the scientific community and providing robust and reliable software that is well supported. The amount of genomic data is growing very quickly, and there is strong demand for high quality solutions such as Qlucore."
Digital Edition
Lab Asia 31.2 April 2024
April 2024
In This Edition Chromatography Articles - Approaches to troubleshooting an SPE method for the analysis of oligonucleotides (pt i) - High-precision liquid flow processes demand full fluidic c...
View all digital editions
Events
Microbiology Society Annual Conference 2024
Apr 08 2024 Edinburgh 2024
Apr 09 2024 Munich, Germany
Apr 10 2024 Helsinki, Finland
Analytica Anacon India & IndiaLabExpo
Apr 15 2024 Mumbai, India
Apr 16 2024 Moscow, Russia